Author: Gurinder Khera

As the Founder of US Pharma Marketing, I launched the platform to address a clear gap in the pharmaceutical, biotech, and life sciences industries: a centralized resource for marketing and sales insights tailored to the unique challenges of these sectors.With the rapid growth and increasing complexity of these industries, professionals need up-to-date, expert-driven content that empowers them to navigate emerging trends, regulatory changes, and evolving customer expectations. At US Pharma Marketing, we provide the latest industry updates, in-depth analysis, actionable strategies, and expert advice, helping professionals stay competitive and innovative.Our platform serves marketers, sales leaders, and business professionals across pharma, biotech, and life sciences, offering the tools they need to drive growth and success in a fast-paced healthcare landscape.
FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising
Posted in

FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising

For years, pharmaceutical marketing teams have operated in a gray zone—especially on social media. Branded content, … FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC AdvertisingRead more

by Gurinder Khera••0